The objectives of this innovative meeting were to discuss developments in the management of genitourinary cancer worldwide and how Italian clinicians could harness these innovations in their everyday practice. The 2-day meeting was divided into two sessions covering kidney and prostate cancer, and a large part was given over to the presentation and discussion of new recently presented data at major international congresses in 2012. There were no restrictions on content and all subjects from pathology, surgery and genetics to therapy and patient outcomes were covered.
The treating scenario in genitourinary oncology: what is new? Part 2 / Bracarda, S.; Montironi, Rodolfo; Porta, C.; Szczylic, C.; Bearz, A.; Cartenì, G.; Bellmunt, J.. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - STAMPA. - 9:6(2013), pp. 803-806. [10.2217/fon.13.46]
The treating scenario in genitourinary oncology: what is new? Part 2.
MONTIRONI, RODOLFO;
2013-01-01
Abstract
The objectives of this innovative meeting were to discuss developments in the management of genitourinary cancer worldwide and how Italian clinicians could harness these innovations in their everyday practice. The 2-day meeting was divided into two sessions covering kidney and prostate cancer, and a large part was given over to the presentation and discussion of new recently presented data at major international congresses in 2012. There were no restrictions on content and all subjects from pathology, surgery and genetics to therapy and patient outcomes were covered.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
